Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesClinical Evaluation of De Marco Formula as an Adjunctive Therapy for Infected Ischemic Diabetic Foot: A Prospective Randomized Controlled Trial
Canadian Journal of Clinical Pharmacology, 08/17/09
Duarte HA et al. – The treatment with DMF for 52 days as an adjuvant for the conventional therapy was associated with a lower need for major amputations. It was also well tolerated and safe.
Related Articles
Exploring the complex care of the diabetic foot ulcer
JAAPA, 10/30/09
Relevance Score: 70%
Effectiveness of insoles used for the prevention of ulceration in the neuropathic diabetic foot: a systematic review
Journal of Diabetes and its Complications, 10/29/09
Relevance Score: 69%
The treatment of diabetic foot infections: focus on ertapenem
Vascular Health and Risk Management, 11/09/09
Relevance Score: 68%
Treatment of nonhealing diabetic foot ulcers with a platelet-derived growth factor gene-activated matrix: Results of a Phase 12 trial
Wound Repair and Regeneration, 11/13/09
Relevance Score: 67%
Management of diabetic foot problems
Journal of Vascular Surgery, 11/03/09
Relevance Score: 67%
Today in Drug Trials...keeping you current
Receive free subspecialty "5-minute updates" via email
Phase I trial of motexafin gadolinium and doxorubicin in the treatment of advanced malignancies
Investigational New Drugs, 12/18/09
ARIAD Announces Full Enrollment in Phase 3 Succeed Trial Evaluating Ridaforolimus in Patients with Metastatic Sarcomas
ARIAD Pharmaceuticals, 12/18/09
Milatuzumab – a promising new immunotherapeutic agent
Expert Opinion on Investigational Drugs, 12/17/09
Today in Other Drugs...keeping you current
Receive free subspecialty "5-minute updates" via email
Meta-analysis of the evidence for a partially hydrolyzed 100% whey formula for the prevention of allergic diseases
Current Medical Research and Opinion, 12/18/09
Vardenafil for the treatment of erectile dysfunction: an overview of the clinical evidence
Clinical Interventions in Aging, 12/18/09
Iron supplementation in the non-dialysis chronic kidney disease patient: oral or intravenous
Current Medical Research and Opinion, 12/18/09
Sponsor
Article Search
Sponsor
Sponsor